IN RE: ZOSTAVAX (ZOSTER VACCINE LIVE) PRODUCTS LIABILITY LITIGATION
Case Number:
2:18-md-02848
Court:
Nature of Suit:
P.I.: Health Care/Pharmaceutical Personal Injury Product Liability
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
-
July 16, 2024
3rd Circ. Backs Tossing Over 1K Suits In Merck Vaccine MDL
The Third Circuit on Tuesday affirmed the dismissal with prejudice of 1,189 cases in multidistrict litigation alleging Merck & Co. Inc.'s shingles vaccine, Zostavax, caused the disease, saying the district court did not abuse its discretion by requiring medical tests to support the claims.
-
October 31, 2023
3rd Circ. Presses For Evidence In Merck Shingles Vax Suit
A Third Circuit judge said Tuesday she was "skeptical" of whether plaintiffs in multidistrict litigation could show proof that Merck's shingles vaccine caused the disease, scrutinizing a district judge's ask for scientific evidence from the plaintiffs prior to dismissing the cases.
-
December 07, 2022
Merck Sheds Nearly 1,200 Shingles Vaccine Suits
A Pennsylvania federal judge has dismissed almost 1,200 suits in a multidistrict litigation over allegations that Merck's shingles vaccine caused the disease after the plaintiffs were unable to show their outbreaks were not caused by a "wild" strain of the virus.
-
October 04, 2022
Shingles Patients Push To Keep Zostavax MDL Alive
Patients alleging that Merck's Zostavax shingles vaccine actually caused shingles have asked a federal judge to keep their suit alive, rejecting the pharmaceutical company's position that lab tests must be provided to prove causation in 1,100 cases.
-
March 31, 2020
Merck Can't Trim Dozens Of Suits From Zostavax MDL
A Pennsylvania federal judge has largely rejected a bid to ax nearly a hundred lawsuits over alleged injuries from the Merck & Co. shingles vaccine Zostavax based on what the pharmaceutical giant argued were deficiencies in fact sheets that plaintiffs were required to submit as part of a multidistrict litigation program.